Evaluation of the Concentration-prediction for Oxygen and Volatile Anesthetic Agents in the 'Draeger Perseus A500' Anesthesia Machine
Studie Zur Evaluation Der Narkosemittel- Und Sauerstoffkonzentrationsvorhersage im Narkosegeraet Perseus-A500 Der Firma Draeger
1 other identifier
observational
20
1 country
1
Brief Summary
The anesthesia machine "Draeger Perseus A 500" has an integrated software which calculates the predicted course of the concentration of oxygen and the volatile anesthetics sevoflurane and desflurane for the next 20 minutes. The Goal of this study was to evaluate the accuracy of this prediction under controlled clinical circumstances. Therefore 20 patients undergoing an operation with general anesthesia were included. They were assigned to a sevoflurane- or desflurane-group by lots. The oxygen- and volatile anesthetic influx into the anesthesia machine's circuit was adjusted following a fixed protocol. The concentration of oxygen and the volatile anesthetic was measured and compared to the predicted values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2017
CompletedFirst Submitted
Initial submission to the registry
February 27, 2018
CompletedFirst Posted
Study publicly available on registry
March 14, 2018
CompletedMarch 16, 2018
March 1, 2018
1.1 years
February 27, 2018
March 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction Error
median prediction error (%) and median absolut prediction error (%) for the concentration of oxygen- and volatile anesthetics
20 minutes period (data collection every 2 seconds)
Study Arms (2)
Sevoflurane
10 patients receiving an anesthesia with sevoflurane
Desflurane
10 patients receiving an anesthesia with desflurane
Eligibility Criteria
Consecutive patients of the surgical department.
You may qualify if:
- patients undergoing an operation under general anesthesia
You may not qualify if:
- body-mass-index \> 35 kg/m2
- pregnancy
- patients who are not able to give informed consent
- patients with relevant comorbidity (ASA-classification \> II), especially cardio-vascular or pulmonary disease
- contraindications for volatile anesthetics (for example disposition for malignant hyperthermia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Erlangen, Bavaria, 91054, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Tino Muenster, Prof. Dr. med.
Department of Anesthesiology
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice director of the Department of Anaesthesiology
Study Record Dates
First Submitted
February 27, 2018
First Posted
March 14, 2018
Study Start
December 15, 2015
Primary Completion
January 10, 2017
Study Completion
January 10, 2017
Last Updated
March 16, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share